![](https://lymphoma.org/wp-content/uploads/2020/08/Research_Timelinev4.jpg)
ASH 2023: Barriers Identified to the Use of CAR T-cell Therapy in Non-Hodgkin Lymphoma
ASH 2023: Barriers Identified to the Use of CAR T-cell Therapy in Non-Hodgkin Lymphoma While chimeric antigen receptor (CAR) T-cell therapy represents a promising treatment option for patients with non-Hodgkin lymphoma (NHL), many community physicians face challenges that make it…